Despite all the attention on technologies that reduce the hands-on role of humans at work — such as self-driving vehicles, robot workers, artificial intelligence, and so on — researchers in the field ...

Nearly half of advanced ovarian cancer patients relapsed after first-line PARP inhibitor maintenance, emphasizing the need for refined postrecurrence strategies. BRCA mutation carriers were more ...

Lumacaftor–ivacaftor (LUM-IVA) is a CFTR modulator approved for children aged >1 year who are homozygous for the F508del variant, targeting the underlying molecular defect. Despite evidence from ...

Erectile dysfunction (ED) affects approximately 50% of men over the age of 40, often leading to significant distress, but it is also quite common in young individuals (26% of newly diagnosed in men ...

Please provide your email address to receive an email when new articles are posted on . Reflectance confocal microscopy (RCM) has not been extensively studied in real-life practice. In a real-life ...

Ruxolitinib cream shows rapid, significant repigmentation in NSV, aligning with phase 3 trial outcomes and suggesting first-line therapy potential, especially for facial involvement. The study's ...